Allergan seeks approval for tear-producing medicine
Allergan has applied for a prior approval supplement (PAS) for Restatsis -- a medication to help patients who suffer from chronic eye dryness increase the production of tears -- according to a Nov. 11 announcement. Read More »
Alerts Sign-up